HomePBYI • NASDAQ
Puma Biotechnology Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 46.01M | 5.12% |
Operating expense | 31.47M | -10.95% |
Net income | 2.97M | 161.77% |
Net profit margin | 6.46 | 158.73% |
Earnings per share | 0.10 | 300.00% |
EBITDA | 6.78M | 1,033.78% |
Effective tax rate | 8.97% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.17M | -13.06% |
Total assets | 196.18M | -8.39% |
Total liabilities | 99.07M | -39.28% |
Total equity | 97.11M | — |
Shares outstanding | 49.64M | — |
Price to book | 1.75 | — |
Return on assets | 4.86% | — |
Return on capital | 6.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.97M | 161.77% |
Cash from operations | 3.61M | -67.88% |
Cash from investing | 1.53M | 108.02% |
Cash from financing | -11.33M | — |
Net change in cash | -6.19M | 21.00% |
Free cash flow | 3.59M | -73.22% |
Previous close
$3.43
Day range
$3.38 - $3.47
Year range
$2.23 - $4.13
Market cap
168.77M USD
Avg Volume
404.92K
P/E ratio
4.41
Dividend yield
-
Primary exchange
NASDAQ
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
172
